Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2018 1
2020 1
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Vlaar APJ, Witzenrath M, van Paassen P, Heunks LMA, Mourvillier B, de Bruin S, Lim EHT, Brouwer MC, Tuinman PR, Saraiva JFK, Marx G, Lobo SM, Boldo R, Simon-Campos JA, Cornet AD, Grebenyuk A, Engelbrecht JM, Mukansi M, Jorens PG, Zerbib R, Rückinger S, Pilz K, Guo R, van de Beek D, Riedemann NC; PANAMO study group. Vlaar APJ, et al. Among authors: boldo r. Lancet Respir Med. 2022 Dec;10(12):1137-1146. doi: 10.1016/S2213-2600(22)00297-1. Epub 2022 Sep 7. Lancet Respir Med. 2022. PMID: 36087611 Free PMC article. Clinical Trial.
Pharmacokinetic analysis of vilobelimab, anaphylatoxin C5a and antidrug antibodies in PANAMO: a phase 3 study in critically ill,  invasively mechanically ventilated COVID-19 patients.
Lim EHT, Vlaar APJ, de Bruin S, Rückinger S, Thielert C, Habel M, Guo R, Burnett BP, Dickinson J, Brouwer MC, Riedemann NC, van de Beek D; PANAMO study group. Lim EHT, et al. Intensive Care Med Exp. 2023 Jun 19;11(1):37. doi: 10.1186/s40635-023-00520-8. Intensive Care Med Exp. 2023. PMID: 37332066 Free PMC article.
Early and Late Mortality Following Discharge From the ICU: A Multicenter Prospective Cohort Study.
Rosa RG, Falavigna M, Robinson CC, Sanchez EC, Kochhann R, Schneider D, Sganzerla D, Dietrich C, Barbosa MG, de Souza D, Rech GS, Dos Santos RDR, da Silva AP, Santos MM, Dal Lago P, Sharshar T, Bozza FA, Teixeira C; Quality of Life After ICU Study Group Investigators and the BRICNet. Rosa RG, et al. Crit Care Med. 2020 Jan;48(1):64-72. doi: 10.1097/CCM.0000000000004024. Crit Care Med. 2020. PMID: 31609775
The Burden of Mental Illness Among Survivors of Critical Care-Risk Factors and Impact on Quality of Life: A Multicenter Prospective Cohort Study.
Teixeira C, Rosa RG, Sganzerla D, Sanchez EC, Robinson CC, Dietrich C, Kochhann R, de Souza D, Rech GS, da R Dos Santos R, Schneider D, Boldo R, Sharshar T, Bozza FA, Falavigna M, Friedman G. Teixeira C, et al. Among authors: boldo r. Chest. 2021 Jul;160(1):157-164. doi: 10.1016/j.chest.2021.02.034. Epub 2021 Feb 25. Chest. 2021. PMID: 33640377
Quality of life after intensive care unit: a multicenter cohort study protocol for assessment of long-term outcomes among intensive care survivors in Brazil.
Robinson CC, Rosa RG, Kochhann R, Schneider D, Sganzerla D, Dietrich C, Sanchez ÉC, Dutra FH, Oliveira MQ, Anzolin LB, Menezes SF, Jeffman R, Souza D, Silva SFD, Cruz LN, Boldo R, Cardoso JR, Birriel DC, Gamboa MN, Machado AS, Andrade JMS, Alencar C, Teixeira MC, Vieira SRR, Moreira FC, Amaral A, Silveira APM, Teles JMM, Oliveira DC, Oliveira Júnior LC, Castro LCE, Silva MSD, Neves RT, Gomes RA, Ribeiro CM, Cavalcanti AB, Oliveira RP, Maccari JG, Berto PP, Martins LA, Santos RLDS, Ue LY, Hammes LS, Sharshar T, Bozza F, Falavigna M, Teixeira C. Robinson CC, et al. Among authors: boldo r. Rev Bras Ter Intensiva. 2018 Oct-Dec;30(4):405-413. doi: 10.5935/0103-507X.20180063. Epub 2019 Jan 10. Rev Bras Ter Intensiva. 2018. PMID: 30652780 Free PMC article.